AstraZeneca
Website: AstraZeneca
Index: FTSE 100
EPIC: AZN
Sector: Pharmaceuticals & Biotechnology
Subsector: Pharmaceuticals
Market Cap:
£164.96B
Payout Frequency: Semi-Annual
AstraZeneca Annual Dividend Yield - 2.06%
Dividends Used in Calculation:
22/02/2024 |
25/03/2024 |
2nd Interim |
197.00¢ |
USX |
08/08/2024 |
09/09/2024 |
1st Interim |
100.00¢ |
USX |
Total (Annual Dividends Per Share):
219.53p
(Using exchange rate on 03/06/2025 $1 = £0.73915)
Dividend Yield = Annual Dividends Per Share (219.53p) ÷ Share Price (10638p) = 2.06%
AstraZeneca Dividend History
20/02/2025 | 24/03/2025 | 2nd Interim | 210.00¢ | USX |
08/08/2024 | 09/09/2024 | 1st Interim | 100.00¢ | USX |
22/02/2024 | 25/03/2024 | 2nd Interim | 197.00¢ | USX |
10/08/2023 | 11/09/2023 | 1st Interim | 93.00¢ | USX |
23/02/2023 | 27/03/2023 | 2nd Interim | 197.00¢ | USX |
11/08/2022 | 12/09/2022 | 1st Interim | 93.00¢ | USX |
24/02/2022 | 28/03/2022 | 2nd Interim | 197.00¢ | USX |
12/08/2021 | 13/09/2021 | 1st Interim | 90.00¢ | USX |
25/02/2021 | 29/03/2021 | 2nd Interim | 190.00¢ | USX |
13/08/2020 | 14/09/2020 | 1st Interim | 90.00¢ | USX |
27/02/2020 | 30/03/2020 | 2nd Interim | 190.00¢ | USX |
08/08/2019 | 09/09/2019 | 1st Interim | 90.00¢ | USX |
08/08/2019 | 09/09/2019 | Interim | 90.00¢ | USX |
28/02/2019 | 27/03/2019 | 2nd Interim | 190.00¢ | USX |
09/08/2018 | 10/09/2018 | 1st Interim | 90.00¢ | USX |
15/02/2018 | 19/03/2018 | 2nd Interim | 190.00¢ | USX |
10/08/2017 | 11/09/2017 | 1st Interim | 90.00¢ | USX |
16/02/2017 | 20/03/2017 | 2nd Interim | 190.00¢ | USX |
11/08/2016 | 12/09/2016 | 1st Interim | 90.00¢ | USX |
17/02/2016 | 21/03/2016 | 2nd Interim | 190.00¢ | USX |
13/08/2015 | 14/09/2015 | 1st Interim | 90.00¢ | USX |
19/02/2015 | 23/03/2015 | 2nd Interim | 190.00¢ | USX |
13/08/2014 | 15/09/2014 | 1st Interim | 90.00¢ | USX |
19/02/2014 | 24/03/2014 | 2nd Interim | 190.00¢ | USX |
14/08/2013 | 16/09/2013 | 1st Interim | 90.00¢ | USX |
2024 | | 100.000 | 197.000 | USX | 297.000 | 2.41 |
2023 | | 93.000 | 197.000 | USX | 290.000 | 0.00 |
2022 | | 93.000 | 197.000 | USX | 290.000 | 3.57 |
2021 | | 90.000 | 190.000 | USX | 280.000 | 0.00 |
2020 | | 90.000 | 190.000 | USX | 280.000 | -24.32 |
2019 | 90.000 | 90.000 | 190.000 | USX | 370.000 | 32.14 |
2018 | | 90.000 | 190.000 | USX | 280.000 | 0.00 |
2017 | | 90.000 | 190.000 | USX | 280.000 | 0.00 |
2016 | | 90.000 | 190.000 | USX | 280.000 | 0.00 |
2015 | | 90.000 | 190.000 | USX | 280.000 | 0.00 |
2014 | | 90.000 | 190.000 | USX | 280.000 | 211.11 |
2013 | | 90.000 | | USX | 90.000 | |
AstraZeneca Dividend Calculator
AstraZeneca Dividend Growth
Dividend Growth (1Y) |
7.81%
|
Dividend CAGR (5Y) |
2.6%
|
Years of Growth |
–
|
Payout Ratio |
63.6%
|
Buyback Yield |
-0.08%
|
Shareholder Yield |
2.15%
|
AstraZeneca Valuation & Profitability
P/E Ratio (TTM) |
27.66
|
Forward P/E |
15.42
|
P/FCF |
–
|
Earnings Yield |
3.65%
|
FCF Yield |
5.23%
|
ROE |
19.79%
|
ROCE |
17.65%
|
Profit Margin |
14.14%
|
Operating Margin |
24.75%
|
Gross Margin |
82.44%
|